120 related articles for article (PubMed ID: 3099046)
21. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
22. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
[TBL] [Abstract][Full Text] [Related]
23. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].
Gohji K; Hamami G; Kamidono S
Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191
[TBL] [Abstract][Full Text] [Related]
24. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation.
Kim KN; Pie JE; Park JH; Park YH; Kim HW; Kim MK
J Nutr Biochem; 2006 Jul; 17(7):454-62. PubMed ID: 16443354
[TBL] [Abstract][Full Text] [Related]
26. Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.
Takahashi N; Iwahori A; Breitman TR; Fukui T
Oncol Res; 1997; 9(10):527-33. PubMed ID: 9507530
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
28. Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.
Gullberg U; Nilsson E; Einhorn S; Olsson I
Exp Hematol; 1985 Aug; 13(7):675-9. PubMed ID: 2411582
[TBL] [Abstract][Full Text] [Related]
29. An antiestrogenic action of interferons in human breast cancer cells.
Iacobelli S; Natoli C; Arnò E; Sbarigia G; Gaggini C
Anticancer Res; 1986; 6(6):1391-4. PubMed ID: 2434018
[TBL] [Abstract][Full Text] [Related]
30. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells.
Hurnanen D; Chan HM; Kubow S
J Pharmacol Exp Ther; 1997 Dec; 283(3):1520-8. PubMed ID: 9400029
[TBL] [Abstract][Full Text] [Related]
31. Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media.
de la Maza LM; Peterson EM
Cancer Res; 1988 Jan; 48(2):346-50. PubMed ID: 3121172
[TBL] [Abstract][Full Text] [Related]
32. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
34. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
35. Synergistic antitumor effects of natural human tumor necrosis factor-alpha and natural human interferon-alpha or -gamma on human cancer cell lines.
Shiiki S; Fuchimoto S; Orita K
Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):87-97. PubMed ID: 2501839
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon.
Tsai SC; Gaffney EV
J Natl Cancer Inst; 1987 Jul; 79(1):77-81. PubMed ID: 3110477
[TBL] [Abstract][Full Text] [Related]
37. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
38. Variants of a human monocytic leukemia cell line (THP-1): induction of differentiation by retinoic acid, interferon-gamma, and T-lymphocyte-derived differentiation-inducing activity.
Nakamura T; Hemmi H; Aso H; Ishida N
J Natl Cancer Inst; 1986 Jul; 77(1):21-7. PubMed ID: 3088310
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells.
Marth C; Widschwendter M; Daxenbichler G
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):123-6. PubMed ID: 8274426
[TBL] [Abstract][Full Text] [Related]
40. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma.
Harvat BL; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):289-300. PubMed ID: 8838859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
